Clinical characterization of canine lymphoma and chemotherapy resistance mechanisms; prevention of chemotherapy side effects; applications for treatment with oral low-dose metronomic chemotherapy and methods to assess clinical response; novel therapies for canine lymphoma and hemangiosarcoma.
Medical oncology for companion animals, canine lymphoma, canine hemangiosarcoma, chemotherapy
Crouse, Z., Phillips, B., Flory, A., Mahoney, J., Richter, K., Kidd, L. Post-chemotherapy perforation in cats with discrete intermediate- or large-cell gastrointestinal lymphoma J Feline Med Surg 20: 696-703, 2018.Mahoney, J. A., Fisher, J. C., Snyder, S. A., Hauck, M. L. Feasibility of using gene expression analysis to study canine soft tissue sarcomas Mamm Genome 21: 577-82, 2010.Mahoney, J. A., Bergman, P. J., Camps-Palau, M. A., Hull, T. L. Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat J Vet Intern Med 21: 872-3, 2007.
BA (Biological Sciences) Wellesley College, 2002DVM (Veterinary Medicine) North Carolina State University College of Veterinary Medicine, 2006Diplomate, American College of Veterinary Internal Medicine (Oncology)
The Animal Medical Center (2006 to 2007)
Rotating Internship, Small Animal Medicine and Surgery
North Carolina State University College of Veterinary Medicine (2007 to 2010)
Residency, Medical Oncology